Logo image of CRP.CA

CERES GLOBAL AG CORP (CRP.CA) Stock Fundamental Analysis

TSX:CRP - Toronto Stock Exchange - CA1567701091 - Common Stock - Currency: CAD

2.65  -0.01 (-0.38%)

Fundamental Rating

2

Overall CRP gets a fundamental rating of 2 out of 10. We evaluated CRP against 18 industry peers in the Consumer Staples Distribution & Retail industry. While CRP seems to be doing ok healthwise, there are quite some concerns on its profitability. CRP is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CRP had positive earnings in the past year.
CRP had a positive operating cash flow in the past year.
In multiple years CRP reported negative net income over the last 5 years.
Of the past 5 years CRP 4 years had a positive operating cash flow.
CRP.CA Yearly Net Income VS EBIT VS OCF VS FCFCRP.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

1.2 Ratios

The Return On Assets of CRP (0.66%) is worse than 66.67% of its industry peers.
CRP has a Return On Equity of 1.28%. This is in the lower half of the industry: CRP underperforms 66.67% of its industry peers.
CRP's Return On Invested Capital of 2.32% is on the low side compared to the rest of the industry. CRP is outperformed by 77.78% of its industry peers.
Industry RankSector Rank
ROA 0.66%
ROE 1.28%
ROIC 2.32%
ROA(3y)-0.67%
ROA(5y)0.64%
ROE(3y)-1.74%
ROE(5y)1.08%
ROIC(3y)N/A
ROIC(5y)N/A
CRP.CA Yearly ROA, ROE, ROICCRP.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10

1.3 Margins

CRP has a worse Profit Margin (0.23%) than 66.67% of its industry peers.
In the last couple of years the Profit Margin of CRP has declined.
With a Operating Margin value of 0.74%, CRP is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
CRP's Operating Margin has improved in the last couple of years.
CRP's Gross Margin of 2.84% is on the low side compared to the rest of the industry. CRP is outperformed by 88.89% of its industry peers.
In the last couple of years the Gross Margin of CRP has grown nicely.
Industry RankSector Rank
OM 0.74%
PM (TTM) 0.23%
GM 2.84%
OM growth 3Y16.01%
OM growth 5YN/A
PM growth 3Y-14.08%
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y3.22%
CRP.CA Yearly Profit, Operating, Gross MarginsCRP.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CRP is destroying value.
CRP has about the same amout of shares outstanding than it did 1 year ago.
CRP has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CRP has an improved debt to assets ratio.
CRP.CA Yearly Shares OutstandingCRP.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CRP.CA Yearly Total Debt VS Total AssetsCRP.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 3.29 indicates that CRP is not in any danger for bankruptcy at the moment.
CRP has a better Altman-Z score (3.29) than 66.67% of its industry peers.
The Debt to FCF ratio of CRP is 7.70, which is on the high side as it means it would take CRP, 7.70 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CRP (7.70) is worse than 61.11% of its industry peers.
A Debt/Equity ratio of 0.48 indicates that CRP is not too dependend on debt financing.
CRP has a Debt to Equity ratio of 0.48. This is amongst the best in the industry. CRP outperforms 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 7.7
Altman-Z 3.29
ROIC/WACC0.25
WACC9.14%
CRP.CA Yearly LT Debt VS Equity VS FCFCRP.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.54 indicates that CRP should not have too much problems paying its short term obligations.
CRP's Current ratio of 1.54 is amongst the best of the industry. CRP outperforms 83.33% of its industry peers.
CRP has a Quick Ratio of 1.54. This is a bad value and indicates that CRP is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.47, CRP is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 0.47
CRP.CA Yearly Current Assets VS Current LiabilitesCRP.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1

3. Growth

3.1 Past

The earnings per share for CRP have decreased strongly by -65.51% in the last year.
The Earnings Per Share has been decreasing by -7.53% on average over the past years.
CRP shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.91%.
The Revenue has been growing by 15.98% on average over the past years. This is quite good.
EPS 1Y (TTM)-65.51%
EPS 3Y-7.53%
EPS 5YN/A
EPS Q2Q%-114.63%
Revenue 1Y (TTM)-14.91%
Revenue growth 3Y7.14%
Revenue growth 5Y15.98%
Sales Q2Q%-22.06%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CRP.CA Yearly Revenue VS EstimatesCRP.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
CRP.CA Yearly EPS VS EstimatesCRP.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

2

4. Valuation

4.1 Price/Earnings Ratio

CRP is valuated quite expensively with a Price/Earnings ratio of 29.44.
61.11% of the companies in the same industry are cheaper than CRP, based on the Price/Earnings ratio.
CRP's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 29.35.
Industry RankSector Rank
PE 29.44
Fwd PE N/A
CRP.CA Price Earnings VS Forward Price EarningsCRP.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CRP is valued a bit cheaper than the industry average as 61.11% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CRP is valued a bit cheaper than 61.11% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.88
EV/EBITDA 7.23
CRP.CA Per share dataCRP.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CRP!.
Industry RankSector Rank
Dividend Yield N/A

CERES GLOBAL AG CORP

TSX:CRP (3/7/2025, 7:00:00 PM)

2.65

-0.01 (-0.38%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)02-13 2025-02-13
Earnings (Next)05-13 2025-05-13
Inst Owners69.55%
Inst Owner ChangeN/A
Ins Owners0.36%
Ins Owner ChangeN/A
Market Cap82.52M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 29.44
Fwd PE N/A
P/S 0.07
P/FCF 5.88
P/OCF 5.01
P/B 0.38
P/tB 0.39
EV/EBITDA 7.23
EPS(TTM)0.09
EY3.4%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.45
FCFY17%
OCF(TTM)0.53
OCFY19.94%
SpS38.86
BVpS7
TBVpS6.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.66%
ROE 1.28%
ROCE 3.32%
ROIC 2.32%
ROICexc 2.36%
ROICexgc 2.43%
OM 0.74%
PM (TTM) 0.23%
GM 2.84%
FCFM 1.16%
ROA(3y)-0.67%
ROA(5y)0.64%
ROE(3y)-1.74%
ROE(5y)1.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y36.03%
ROICexcg growth 5YN/A
ROICexc growth 3Y35.85%
ROICexc growth 5YN/A
OM growth 3Y16.01%
OM growth 5YN/A
PM growth 3Y-14.08%
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y3.22%
F-Score5
Asset Turnover2.89
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 7.7
Debt/EBITDA 5.68
Cap/Depr 26.14%
Cap/Sales 0.2%
Interest Coverage 1.29
Cash Conversion 90.01%
Profit Quality 504.38%
Current Ratio 1.54
Quick Ratio 0.47
Altman-Z 3.29
F-Score5
WACC9.14%
ROIC/WACC0.25
Cap/Depr(3y)26.77%
Cap/Depr(5y)49.33%
Cap/Sales(3y)0.18%
Cap/Sales(5y)0.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-65.51%
EPS 3Y-7.53%
EPS 5YN/A
EPS Q2Q%-114.63%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.91%
Revenue growth 3Y7.14%
Revenue growth 5Y15.98%
Sales Q2Q%-22.06%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-43.2%
EBIT growth 3Y24.29%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-80.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-78.44%
OCF growth 3YN/A
OCF growth 5YN/A